Zomacton Kit
FDA Label NDC 55566-1901

48 label sections · Submitted to the FDA by Ferring Pharmaceuticals Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Ferring Pharmaceuticals Inc. for the product Zomacton (NDC 55566-1901). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 pediatric patients, 1.2 adult patients, 2.1 administration and use instructions, 2.2 pediatric dosage, 2.3 adult dosage, 2.4 reconstitution, 3 dosage forms and strengths, 4 contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.